Inventor · disambiguated record
Mario Mezler
Also filed as: MEZLER MARIO
24 granted patents·10 pending applications·148 citations·filing 2000–2024
94Inventor score
Top patents by PatentIndex Score
34 records- 0193US8642587B2Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapyLANGE UDO·Filed 2010·Granted Feb 4, 2014·62 cites·19 claims
- 0290US8420670B24-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapyAMBERG WILHELM·Filed 2008·Granted Apr 16, 2013·17 cites·18 claims
- 0388US8653100B2Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapyOCHSE MICHAEL·Filed 2009·Granted Feb 18, 2014·17 cites·20 claims
- 0488US8563617B2Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapyAMBERG WILHELM·Filed 2010·Granted Oct 22, 2013·13 cites·21 claims
- 0588US8440694B2Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptorTURNER SEAN COLM·Filed 2012·Granted May 14, 2013·12 cites·13 claims
- 0680US10556907B2Fused heterocyclic compounds as S1P modulatorsABBVIE INC·Filed 2016·Granted Feb 11, 2020·5 cites·12 claims
- 0780US7790727B2Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorABBOTT GMBH & CO KG·Filed 2008·Granted Sep 7, 2010·4 cites·31 claims
- 0878US8664214B2Small molecule potentiators of metabotropic glutamate receptors IBRAJE WILFRIED·Filed 2011·Granted Mar 4, 2014·5 cites·19 claims
- 0977US9242933B2Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)GENESTE HERVE·Filed 2008·Granted Jan 26, 2016·3 cites·18 claims
- 1074US8242102B2Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorTURNER SEAN COLM·Filed 2008·Granted Aug 14, 2012·2 cites·23 claims
- 1172US9096619B2Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2013·Granted Aug 4, 2015·1 cites·20 claims
- 1271US8957089B2Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2013·Granted Feb 17, 2015·1 cites·15 claims
- 1371US8314120B2Small molecule potentiators of metabotropic glutamate receptorsBRAJE WILFRIED·Filed 2011·Granted Nov 20, 2012·2 cites·32 claims
- 1471US6794149B1GABA B receptorsBAYER AG·Filed 2000·Granted Sep 21, 2004·1 cites·1 claims
- 1571US2025296917A1Spiro-cyclic amine derivatives as s1p modulatorsABBVIE DEUTSCHLAND·Filed 2024·Application pending·0 cites
- 1668US8507469B2Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorSCHULTZ THOMAS·Filed 2008·Granted Aug 13, 2013·2 cites·44 claims
- 1767US8877794B2Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapyPOHLKI FRAUKE·Filed 2011·Granted Nov 4, 2014·1 cites·18 claims
- 1865US7906120B2Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR)ABBOTT LAB·Filed 2007·Granted Mar 15, 2011·0 cites·21 claims
- 1963US9255146B2Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereofABBVIE DEUTSCHLAND·Filed 2013·Granted Feb 9, 2016·0 cites·6 claims
- 2063US2019233510A1NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOFABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 2162US2022169620A1Spiro-cyclic amine derivatives as s1p modulatorsABBVIE DEUTSCHLAND·Filed 2021·Application pending·0 cites
- 2261US10040852B2Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereofABBVIE DEUTSCHLAND·Filed 2016·Granted Aug 7, 2018·0 cites·14 claims
- 2359US2005136511A1GABA B receptorsFiled 2004·Application pending·0 cites
- 2458US8293913B2Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptorTURNER SEAN COLM·Filed 2008·Granted Oct 23, 2012·0 cites·13 claims
- 2557US9067871B2Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2013·Granted Jun 30, 2015·0 cites·6 claims
- 2654US9238619B2Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2014·Granted Jan 19, 2016·0 cites·26 claims
- 2754US2011142845A1NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOFABBOTT LAB·Filed 2010·Application pending·0 cites
- 2850US2006177816A1Cellular RhoGTPase activation assayABBOTT GMBH & CO KG·Filed 2006·Application pending·0 cites
- 2946US9045459B2Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapyPOHLKI FRAUKE·Filed 2011·Granted Jun 2, 2015·0 cites·10 claims
- 3043US2011086863A1Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptorABBOTT GMBH & CO KG·Filed 2010·Application pending·0 cites
- 3141US9309200B2Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapyAMBERG WILHELM·Filed 2012·Granted Apr 12, 2016·0 cites·23 claims
- 3241US2015158842A1Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2015·Application pending·0 cites
- 3339US2021147381A11,2,3,4-substituted quinoline compounds as sip modulatorsABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 3436US2020055817A1Spiro-compounds as sip modulatorsABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →